Skip to Content


In the US, Iopamidol (iopamidol systemic) is a member of the drug class non-ionic iodinated contrast media and is used to treat Endoscopy or Radiology Premedication.

US matches:

UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Iodinated x-ray contrast media

Chemical Name

1,3-Benzenedicarboxamide, N,N'-bis[2-hydroxy-1-(hydroxymetyl)etyl]-5-[(2-hydroxy-1-oxopropyl)amino]-2,4,6-triiodo-, (S)-

Foreign Names

  • Iopamidolum (Latin)
  • Iopamidol (German)
  • Iopamidol (French)
  • Iopamidol (Spanish)

Generic Names

  • Iopamidol (OS: USAN, JAN, DCF, BAN)
  • Iopamidolo (OS: DCIT)
  • B 15 000 (IS)
  • SQ 13396 (IS: Squibb)
  • Iopamidol (PH: BP 2016, JP XVI, Ph. Eur. 8, USP 38)
  • Iopamidolo (PH: Ph. Eur. 8)
  • Iopamidolum (PH: Ph. Eur. 8)

Brand Names

  • Amidol
    Incepta, Bangladesh
  • Bystage
    Teva Seiyaku, Japan
  • Diapamiro
    Techno, Bangladesh
  • Gastromiro
    Bracco, Lithuania; Bracco, Netherlands; Bracco Imaging, Estonia; Bracco Imaging Italia, Italy; Bracco Österreich, Austria; Bracco UK, United Kingdom; Rovi, Portugal
  • Iopamed
    Medifarma, Peru
  • Iopamidol Biomendi
    Biomendi, Spain
  • Iopamidol G.E.S.
    Ges Genericos, Spain
  • Iopamidol HK
    Hikari Seiyaku, Japan
  • Iopamidolo Bioindustria Lim
    Bioindustria, Georgia; Bioindustria Lim, Italy
  • Iopamigita
    Agfa, Estonia; Agfa, Poland; Agfa HealthCare, Belgium; Agfa Healthcare Imaging Agents, Germany; Farmavita, Croatia (Hrvatska); Insight Agents, Bulgaria; Insight Agents, Romania; Insights, Portugal; Solupharm, Georgia
  • Iopamiro
    Bracco, Bosnia & Herzegowina; Bracco, Greece; Bracco, Croatia (Hrvatska); Bracco, Israel; Bracco, Italy; Bracco, Lithuania; Bracco, Netherlands; Bracco, Portugal; Bracco, Romania; Bracco, Singapore; Bracco Imaging, Estonia; Bracco Sine Pharmaceutical, China; Bracco Suisse, Switzerland; Patheon, Bulgaria; Rovi, Spain; Santa-Farma, Turkey
  • Iopamiron
    Bayer, Ecuador; Bayer, Peru; Bayer Yakuhin, Japan; Bracco, France
  • Iopamiron (Iopamidol and Trometamol)
    Bayer BSP, Argentina
  • Iopasen
    Galenica Senese, Georgia; Galenica Senese, Italy
  • Iopathek
    Medithek, Germany
  • Jopamiro
    Bracco Österreich, Austria
  • Lopidam
    Beximco, Bangladesh
  • Midoscan
    Laboratorios Biosano, Chile
  • Moiopamin
    Hikari Seiyaku, Japan
  • Niopam
    Bracco UK, United Kingdom
  • Opacrile (Iopamidol and Trometamol)
    Bacon, Argentina
  • Oypalomin
    Fuji Seiyaku, Japan
  • Pamiray
    Biem, Turkey; Dong Kook, Georgia
  • Pamiray-300
    Biem, Turkey
  • Pamiray-370
    Biem, Turkey
  • Pamiscan
    Medis, Tunisia
  • Radoso
    Alapis Pharma, Greece
  • Scanlux
    Iasis Pharma, Greece; Iberoinversa, Spain; Sanochemia, Bulgaria; Sanochemia, Georgia; Sanochemia, Hungary; Sanochemia, Portugal; Sanochemia, Romania; Sanochemia, Tunisia; Sanochemia Diagnostics International, Switzerland; Sanochemia Pharmazeutika, Austria
  • Solutrast
    Bracco Imaging, Germany
  • Solutrast M
    Bracco Imaging, Germany
  • Unilux
    Sanochemia, Germany; Sanochemia Pharmazeutika, Austria
  • Uniray
    Unijules, Georgia


BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.